Pharmaceutical Giants
- All
- News
- Videos
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
Johnson & Johnson Risks UK Lawsuit Over Powder Cancer Claim By Thousands
UK claimants on Wednesday announced legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.
-
Kiran Mazumdar-Shaw Opposes Karnataka's Job Quota Bill, Minister Responds
Kiran Mazumdar-Shaw, the founder of pharmaceutical giant Biocon, on Wednesday opposed the proposal to reserve private jobs for local hires in Karnataka, which houses the country's information technology hub Bengaluru.
-
Fire At Pharmaceuticals Giant Building In Denmark, Third Case In A Month
A fire broke out on Tuesday at a Novo Nordisk building in Denmark, the pharmaceuticals giant told Reuters.
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
Johnson & Johnson Proposes $9 Billion To Settle Cancer Claims: 5 Facts
Pharmaceutical giant Johnson & Johnson will pay $8.9 billion to settle thousands of lawsuits alleging that the talcum in its iconic baby powder caused cancer. However, the US company's proposal will need the approval of a bankruptcy court.
-
Johnson & Johnson's $9 Billion Offer To Settle 'Talc Caused Cancer' Claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Pfizer To Acquire Cancer Treatment Biotech Firm Seagen For $43 Billion
US pharmaceutical giant Pfizer announced Monday it had reached a deal to buy biotech firm Seagen, specialising in innovative cancer treatment, for $43 billion.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
Johnson & Johnson Risks UK Lawsuit Over Powder Cancer Claim By Thousands
UK claimants on Wednesday announced legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.
-
Kiran Mazumdar-Shaw Opposes Karnataka's Job Quota Bill, Minister Responds
Kiran Mazumdar-Shaw, the founder of pharmaceutical giant Biocon, on Wednesday opposed the proposal to reserve private jobs for local hires in Karnataka, which houses the country's information technology hub Bengaluru.
-
Fire At Pharmaceuticals Giant Building In Denmark, Third Case In A Month
A fire broke out on Tuesday at a Novo Nordisk building in Denmark, the pharmaceuticals giant told Reuters.
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
Johnson & Johnson Proposes $9 Billion To Settle Cancer Claims: 5 Facts
Pharmaceutical giant Johnson & Johnson will pay $8.9 billion to settle thousands of lawsuits alleging that the talcum in its iconic baby powder caused cancer. However, the US company's proposal will need the approval of a bankruptcy court.
-
Johnson & Johnson's $9 Billion Offer To Settle 'Talc Caused Cancer' Claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Pfizer To Acquire Cancer Treatment Biotech Firm Seagen For $43 Billion
US pharmaceutical giant Pfizer announced Monday it had reached a deal to buy biotech firm Seagen, specialising in innovative cancer treatment, for $43 billion.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
